ClinicalTrials.Veeva

Menu

Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

H

HairDx

Status and phase

Completed
Phase 1

Conditions

Androgenetic Alopecia

Treatments

Drug: Finasteride

Study type

Interventional

Funder types

Industry

Identifiers

NCT01052870
HairDx2009

Details and patient eligibility

About

Previous studies of finasteride treatment in women with hair loss have failed to show positive results, yet, some women have responded anecdotally. Given that polymorphisms of the androgen receptor gene which confer androgen sensitivity impact male response to finasteride therapy, it was hypothesized that the same polymorphism in women may identify the group that will respond. This study is designed to test the impact of finasteride therapy on hair loss in postmenopausal women.

Full description

Androgen sensitivity in the cell is determined by the number of Cytosine-Adenine-Guanine repeats in the Androgen Receptor gene. Lower CAG repeats have been associated in previous studies with androgenic conditions such as acne, hirsutism and hair loss in men and women. Keeping this in mind, we tested women with hair loss in the frontal or vertex area, for their AR genotype. Patients were randomized to placebo or 1 mg finasteride therapy for 6 months. Global photographs and 2 tatooed areas of 1cm2 each were measured monthly to assess global appearance and hair counts for medication impact.

Enrollment

12 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women with hair loss

Exclusion criteria

  • pre menopausal,
  • metabolic or medication or non-androgenetic causes of hair loss,
  • diffuse hair loss

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

12 participants in 2 patient groups

androgen receptor gene polymorphism
Other group
Description:
Medication response will be assessed according to androgen receptor genotype
Treatment:
Drug: Finasteride
finasteride
Active Comparator group
Description:
medication for treating androgenetic alopecia in women
Treatment:
Drug: Finasteride

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems